On Wednesday, the European Commission approved BeiGene Ltd’s Tevimbra (tislelizumab) in combination with chemotherapy for the first-line treatment of esophageal squamous cell carcinoma (ESCC) and gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. In ESCC, the expanded indication is for Tevimbra in combination with platinum-based chemotherapy for the first-line treatment of adult patients with unresectable, locally advanced or metastatic cancer whose tumors...

LONDON (Reuters) - BNP Paribas Asset Management will no longer invest in new bonds issued by companies involved in oil and gas exploration and production, according to a strategy update dated November. The French asset manager said its policy aimed to support oil and gas companies with their transition to sustainable energy sources, while screening out those companies which are...

WASHINGTON (Reuters) - The FBI has been investigating a longtime Exxon Mobil ( XOM ) consultant over the contractor's alleged role in a hack-and-leak operation that targeted hundreds of the oil company's biggest critics, according to three people familiar with the matter. The operation involved mercenary hackers who successfully breached the email accounts of environmental activists and others, the sources...

12:04 PM EST, 11/27/2024 (MT Newswires) -- Acuity Brands ( AYI ) said it amended its credit agreement to provide for a delayed draw term loan facility of up to $600 million maturing June 30, 2027. The company may draw the facility in a single borrowing at any time through May 25, subject to certain conditions, according to a Tuesday...